-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Reiterates Outperform on Solid Biosciences, Maintains $14 Price Target

Benzinga·03/11/2026 12:49:53
Listen to the news
Wedbush analyst Laura Chico reiterates Solid Biosciences (NASDAQ:SLDB) with a Outperform and maintains $14 price target.